Bartlett & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-350
Closed -$4K 1194
2023
Q2
$4K Hold
350
﹤0.01% 1023
2023
Q1
$5K Hold
350
﹤0.01% 906
2022
Q4
$6K Hold
350
﹤0.01% 905
2022
Q3
$5K Hold
350
﹤0.01% 938
2022
Q2
$5K Hold
350
﹤0.01% 1029
2022
Q1
$8K Buy
+350
New +$7.09K ﹤0.01% 862
2021
Q4
Sell
-350
Closed -$5K 924
2021
Q3
$5K Hold
350
﹤0.01% 776
2021
Q2
$6K Hold
350
﹤0.01% 748
2021
Q1
$5K Hold
350
﹤0.01% 796
2020
Q4
$5K Hold
350
﹤0.01% 802
2020
Q3
$3K Hold
350
﹤0.01% 779
2020
Q2
$2K Hold
350
﹤0.01% 794
2020
Q1
$2K Buy
+350
New +$2.84K ﹤0.01% 786
2019
Q3
$4K Buy
+350
New +$3.59K ﹤0.01% 796

Other funds holding MDRX

Bartlett & Co's MDRX Position: Q3 2023 in Review

Bartlett & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2023, closing a stake of 350 shares — an estimated $4K sold.

Bartlett & Co first reported a position in MDRX in Q3 2019 and held it in 14 quarters. The position peaked at $8K in Q1 2022. 216 funds tracked by Wall St. Rank hold MDRX as of Q3 2023.

  • Bartlett & Co reported no remaining Veradigm Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bartlett & Co sold 350 Veradigm Inc. Common Stock shares in Q3 2023, an estimated $4K.
  • Bartlett & Co first reported a position in Veradigm Inc. Common Stock in Q3 2019 and held it in 14 quarters.
  • Bartlett & Co's Veradigm Inc. Common Stock position peaked at $8K in Q1 2022.
  • 216 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2023.

Based on Bartlett & Co's 13F filing for Q3 2023, filed 10 Oct 2023.